{"entity":{"id":"nct06581419","kind":"trial","name":"A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors","aka":[],"tldr":"A phase 1/2 trial of IAP0971 in non-small-cell lung cancer, run by SUNHO（China）BioPharmaceutical CO., Ltd., now recruiting.","summary":"A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors is a phase 1/2 interventional study registered as NCT06581419 by SUNHO（China）BioPharmaceutical CO., Ltd., with 78 participants planned, started 2024-12-31 and due to reach its primary completion in 2029-08-01. Interventions recorded: IAP0971.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06581419","url":"https://clinicaltrials.gov/study/NCT06581419"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06581419","phase":"1/2","setting":"A Phase I/II Clinical Study Evaluating Safety, Tolerability, and Efficacy of IAP0971 in Advanced Tumors","sponsor":"SUNHO（China）BioPharmaceutical CO., Ltd.","enrolled":78,"outcomes":[]},"route":"/trials/nct06581419/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}]}}